323 results on '"Thalassemia -- Care and treatment"'
Search Results
2. EU Contract Notice: Spitalul Judetean Giurgiu Issues contract notice|solicitation for 'PURCHASE OF HEMOPHILIA AND THALASEMIA MEDICINES within the National Program for the Treatment of Hemophilia and Thalassemia'
3. Agios' phase 3 ENERGIZE study of mitapivat meets primary endpoint and both key secondary endpoints in adults with NTD alpha- or beta-thalassemia
4. KMU Institute of Medical Sciences Researchers Focus on Beta Thalassemia (Long term thalidomide therapy's efficacy and safety in transfusion-dependent beta thalassemia major patients: a systematic review)
5. Medicines and Healthcare Products Regulatory Agency (MHRA) Researchers Have Published New Data on Sickle Cell Anemia (Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent b-Thalassemia and Sickle Cell Disease with ...)
6. University Hospital Researcher Provides New Insights into Beta Thalassemia (Correlation Between Beta - Stiffness Index And Atherogenic Lipid Indices As A Marker of Subclinical Atherosclerosis in Patients With Beta Thalassemia Major)
7. Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy
8. Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy
9. CRISPR Therapeutics|Vertex's Casgevy secures FDA nod for gene therapy for beta-thalassemia
10. FDA clears first CRISPR treatment for a second disease, beta thalassemia
11. Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia
12. First gene editing therapy to treat beta thalassemia and severe sickle cell disease
13. Therapeutic base editing of human hematopoietic stem cells
14. World's first gene therapy for sickle cell and thalassemia approved in Great Britain: UNITED KINGDOM
15. EMA committee recommends approval of Bristol Myers Squibb's Reblozyl to treat anaemia-associated, NTD beta thalassemia
16. Studies from Southern Medical University Have Provided New Data on Alpha Thalassemia [Quantification of Human Embryonic Zeta-globin Chains In Southeast Asian Deletion (--(Sea)) Carriers]
17. MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent b-thalassemia
18. United Kingdom : MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent ?-thalassemia
19. UK approves first Crispr gene edited therapy for sickle cell disease, beta thalassemia
20. MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia
21. UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia
22. Chinese hospital provides assistance to Lao hospital on treating thalassemia
23. 'purchase Of Medicines For The Treatment Of Patients With Thalassemia Disease For The Purpose Of Realizing The National Program 'combating Rare Diseases' For The Year 2024'
24. New Beta Thalassemia Study Findings Have Been Reported from Mahidol University (Malat1: a Novel Hypothesis On the Pathology of Vascular Injury In Patients With B-thalassemia)
25. Hepatitis E virus prevalence in Egyptian children with transfusion-dependent thalassemia
26. Researchers at University for Health Sciences Report New Data on Beta Thalassemia (Evaluation of Coagulation Parameters and Impact of Transfusion On Coagulation In Patients With Beta Thalassemia Major)
27. New Beta Thalassemia Findings Reported from University of Karachi [Ivs I-5 (G > C) Is Associated With Changes To the Rbc Membrane Lipidome In Response To Hydroxyurea Treatment In Beta-thalassemia Patients]
28. Free treatment to be provided to thalassemia patients: Dr Jamal Nasir
29. New Beta Thalassemia Findings from University of Karachi Outlined (In Vitro and In Vivo Studies for the Investigation of Gamma-globin Gene Induction By Adhatoda Vasica: a Pre-clinical Study of Hbf Inducers for Beta-thalassemia)
30. Doctors call for more attention to plight of thalassemia patients
31. Study Data from University of Milan Update Understanding of Thalassemia (Advancing the Care of Beta-thalassaemia Patients With Novel Therapies)
32. US FDA extends PDUFA goal date of Bristol Myers' sBLA for Reblozyl to treat anaemia in adults with NTD beta thalassemia
33. Studies from Mahidol University Yield New Information about Thalassemia (Long-term Effectiveness Safety, and Tolerability of Twice-daily Dosing With Deferasirox In Children With Transfussion-dependent Thalassemias Unresponsive To Standard ...)
34. The Purchase Of Medicines Used In The Thalassemia, Hemophilia, Hiv Aids Programs As Well As In The Treatment Of Patients Hospitalized In The Medical Wards
35. Editas Medicine to Host Virtual Event to Discuss EDIT-301 Clinical Data from the RUBY Trial for Severe Sickle Cell Disease and the EDITHAL Trial for Transfusion-dependent Beta Thalassemia
36. Editas Medicine to Host Virtual Event to Discuss EDIT-301 Clinical Data from the RUBY Trial for Severe Sickle Cell Disease and the EDITHAL Trial for Transfusion-dependent Beta Thalassemia
37. Investigators from University of Jinan Release New Data on Spinal Cord Injury (Unilateral Bi-portal Endoscopy for the Treatment of Thalassemia With Extramedullary Hematopoietic Compression of the Spinal Cord: Two Case Reports)
38. New International Thalassemia Management Guidelines Launched with Scholarly Contribution from Abu Dhabi
39. DR BHARATI PRAVIN PAWAR LAUNCHES PHASE-III OF THALASSEMIA BAL SEWA YOJANA
40. Bristol Myers Squibb Received European Commission Approval of Reblozyl(r) (luspatercept) for Anemia in Adult Patients with Non-Transfusion-Dependent Beta Thalassemia
41. Bristol Myers Squibb receives European Commission approval of Reblozyl (luspatercept) for anaemia in adult patients with non-transfusion-dependent beta thalassemia
42. New Beta Thalassemia Findings Has Been Reported by Investigators at Southern Medical University (Tea Domain Transcription Factor 4 Modulates Repression of Fetal Haemoglobin By Direct Binding To the Gamma-globin Gene Promoters)
43. Haleeb Foods joined hands with Sundas Foundation to support Thalassemia patients
44. Vertex: Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Reported at the EHA Congress
45. Findings from Gujarat Cancer and Research Institute Provide New Insights into Thalassemia (Unmanipulated Stem Cell Boost for Mixed Chimerism In Transfusion Dependent Thalassemia)
46. Bristol Myers Squibb receives positive CHMP opinion for Reblozyl (luspatercept) for adult patients with anaemia-associated, non-transfusion-dependent (NTD) beta thalassemia
47. Effectiveness and tolerability of twice daily dosing of deferasirox in unresponsive and intolerant transfusion-dependent beta-thalassemia patients: A narrative review
48. Effectiveness of Deferasirox in Pediatric Thalassemia Patients: Experience from a Tertiary Care Hospital of Odisha
49. One-and-done gene therapy promises to transform debilitating disorder
50. EMA grants priority medicines designation to Vertex and CRISPR's CTX001 for transfusion-dependent beta thalassemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.